Articles published by argenx
argenx Announces VYVGART™ Approval in Japan for the Treatment of Generalized Myasthenia Gravis
January 20, 2022
From argenx
Via Business Wire
Tickers
ARGX
argenx Highlights Strategic Priorities for 2022
January 07, 2022
From argenx
Via Business Wire
Tickers
ARGX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>